Last reviewed · How we verify
NCT05003908
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes
Phase 1 trial testing AlloRx in Diabetes in 2 participants. Terminated before completion.
4 April 2025
Quick facts
| Lead sponsor | The Foundation for Orthopaedics and Regenerative Medicine |
|---|---|
| Phase | Phase 1 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 2 |
| Start date | 6 November 2021 |
| Primary completion | 4 April 2025 |
| Estimated completion | 4 April 2025 |
| Sites | 2 locations across Argentina, Antigua and Barbuda |
Drugs / interventions tested
- AlloRx — full drug profile →
Conditions studied
- Diabetes — all drugs for Diabetes →
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Who can join
Eligibility, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Diabetes
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05003908
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of AlloRx
Trials testing the same drug.
- NCT05158933 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure · Phase 1 · withdrawn
- NCT05158114 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia · Phase 1 · withdrawn
- NCT06143527 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS · Phase 1 · recruiting
- NCT05152381 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis · Phase 1 · withdrawn
- NCT05147675 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA · Phase 1 · recruiting
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other The Foundation for Orthopaedics and Regenerative Medicine trials
Trials by the same sponsor.
- NCT05158114 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia · Phase 1 · withdrawn
- NCT05158933 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure · Phase 1 · withdrawn
- NCT07226726 — Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution · Phase 1 · recruiting
- NCT07105371 — Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution · Phase 1 · completed
- NCT06143527 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05003908 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Foundation for Orthopaedics and Regenerative Medicine
- Last refreshed: 8 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05003908.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing